AstraZeneca Announces New Partnership with The National Fish and Wildlife Foundation to Plant One Million Trees
24 Mars 2022 - 12:00PM
Business Wire
Partnership contributes to the AZ Forest
global initiative to plant and maintain 50 million trees worldwide
by the end of 2025
AstraZeneca has partnered with The National Fish and Wildlife
Foundation (NFWF) to plant and sustain one million trees in the
United States by the end of 2025. This initiative is part of the
Company’s flagship Ambition Zero Carbon program to decarbonize its
global operations by eliminating, reducing and substituting for our
greenhouse gas emissions, and become carbon negative across our
value chain by 2030, in line with science-based targets. As part of
its sustainability strategy, AstraZeneca is also putting nature at
the heart of its work, investing in biodiversity through
partnerships with local communities and wildlife experts.
The reforestation partnership with NFWF will help contribute to
the restoration of water quality and wildlife habitats within the
Delaware River Watershed, while at the same time helping to combat
climate change by increasing carbon storage. Several additional
plantings to support vital habitats in additional regions of the
northeastern and southeastern United States will also be funded as
part of this initiative. The new partnership, will fund tree
plantings that maximize the dual role of carbon storage and habitat
restoration, including by:
- Planting streamside forests on farmland, in parks and
residential communities
- Restoring urban tree canopy in cities and towns
- Restoring degraded forest lands
To kick off the partnership, 15 grants have been awarded that
collectively will plant more than 118,000 trees over the next two
years, including 10 grants announced through the Delaware Watershed
Conservation Fund. These projects in Delaware, New Jersey and
Pennsylvania will restore habitat for eastern brook trout, American
eel, bog turtles, river herring and shad, and migratory songbirds.
They also will support green infrastructure in urban
communities.
“Sustainability is embedded in our organizational DNA and guides
our commitment to improving the health of people, society and our
planet. Through our AZ Forest initiative, we’re engaged in
reforestation programs with local partners around the world. We’re
so pleased to be playing our part and helping to restore forests,
diversify wildlife habitats and improve water quality in the
Delaware region to benefit community and ecological resilience,”
said Joris Silon, U.S. Country President, BioPharmaceuticals
Business Unit, AstraZeneca.
The Delaware River watershed covers 13,539 square miles of land
and water, running from the Catskills in New York through
Pennsylvania and New Jersey, ultimately emptying into the Delaware
Bay, where it forms the border between New Jersey and Delaware. The
watershed is home to native brook trout, red knots, river herring,
freshwater mussels, oysters and many other species that are
economically, ecologically and culturally important to the
region.
Urban and suburban waterways play a major role in the
watershed’s communities, with headwaters in neighboring rural
areas. The river basin also provides drinking water to over 15
million people, including communities in New York City, Trenton,
Philadelphia and Wilmington, which also is home to AstraZeneca’s
U.S. headquarters.
“Together with AstraZeneca, we are investing in projects that
are good for climate change, good for fish and wildlife, and good
for local communities,” said Jeff Trandahl, Executive Director and
CEO of NFWF. “It is exciting to see this work come together to
address some of our most pressing environmental challenges by
providing carbon storage, improving habitat and improving access to
natural and recreational resources in under-served
communities.”
Learn more about sustainability at AstraZeneca including
commitments and progress to date in the Company’s 2021
Sustainability Report.
AZ Forest
AZ Forest is AstraZeneca’s initiative to plant and maintain 50
million trees worldwide by the end of 2025 to support global
reforestation and ecological and community resilience through
partnership with local communities, governments and non-profit
organizations. Reforestation helps sequester carbon dioxide,
prevent disease through combatting air pollution and supports the
restoration of biodiversity. Planting trees also helps to reduce
the risks of natural disasters, has social and economic benefits
for communities, and promotes physical and mental wellbeing.
About AstraZeneca
AstraZeneca is a global, science-led biopharmaceutical company
that focuses on the discovery, development and commercialization of
prescription medicines in Oncology, Rare Diseases and
BioPharmaceuticals, including Cardiovascular, Renal &
Metabolism, and Respiratory & Immunology. Based in Cambridge,
UK, AstraZeneca operates in over 100 countries, and its innovative
medicines are used by millions of patients worldwide. For more
information, please visit www.astrazeneca-us.com and follow us on
Twitter @AstraZenecaUS.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220324005259/en/
Media Inquiries Brendan McEvoy +1 302 885 2677 Jillian
Gonzales +1 302 885 2677 US Media Mailbox:
usmediateam@astrazeneca.com
AstraZeneca (NYSE:AZN)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024
AstraZeneca (NYSE:AZN)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024